Innovation in Development of Dermatologic Drugs Approved by the US Food and Drug Administration Between 2012 and 2022

Samir Kamat,Benjamin Ungar,Aneesh Agarwal,Joy Wan,Joseph S. Ross,Ravi Gupta

JAMA DERMATOLOGY（2024）

引用 0|浏览3

暂无评分

摘要

This cross-sectional study characterizes the frequency and degree of innovation of new dermatologic drugs approved by the US Food and Drug Administration (FDA) from 2012 to 2022.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要